$74,725,667

Department of Health and Human Services·Centers for Disease Control and Prevention

to GINKGO BIOWORKS, INC.

biotechactiveONGOING · MOD OF 2025 CONTRACT

WORK BEGAN2025-02-28·LATEST ACTION2026-03-30·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75D30125C20439_7523_-NONE-_-NONE-

Award description

TRAVELER-BASED GENOMIC SURVEILLANCE PROGRAM

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds genomic surveillance of travelers to detect and monitor disease variants in real-time.

Sub-sectors

genomicssurveillance-programvaccine-development-adjacent

Why this matters

Enables early detection of emerging pathogens and variants at borders, critical for pandemic preparedness and public health response.

Supply-chain signal

Drives demand for high-throughput sequencing equipment, bioinformatics platforms, and genomic analysis infrastructure from suppliers like Illumina and others.

U.S.–China competition angle

U.S. investment in genomic surveillance capability counters China's dominance in sequencing technology and positions U.S. biotech leadership in pathogen detection.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002213.

Period of performance

Start

2025-02-28

End

2028-03-21

Status

activein 673 days

Recipient

GINKGO BIOWORKS, INC.

UEI ZRHJUJQSBRA4

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75D30125C20439_7523_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.